Congenital acute myeloid leukemia in Down syndrome

Elena Andreea Moaleș, Mirabela Smaranda Subotnicu, Denisa Boroș, Anca Ivanov, Adriana Mocanu, Magdalena Stârcea, Ingrith Miron


Congenital leukemia is an uncommon myeloproliferative disorder usually diagnosed in the first month of life. Newborns with Down syndrome have an increased susceptibility to acute megakaryoblastic leukemia. We report a case of a newborn with Down syndrome diagnosed with acute myeloid leukemia. The diagnosis was established by clinical and hematological work-up.


congenital leukemia; newborn; Down syndrome

Full Text:



Bajwa RP, Skinner R, Windebank KP, Reid MM. Demographic study of leukaemia presenting within the first three months of life in the northern health region of England. J Clin Pathol 2004; 57:186-188.

Prakash KP, Rau ATK, Bhat ST, Rau AR. Congenital Leukemia – A Diagnostic Dilemma. Indian J Med Paediatr Oncol 2008; 29(4):41-43.

Roy A, Roberts I, Norton A et al. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br J Haematol 2009; 147:3–12.

Sande JE, Arceci RJ, Lampkin BC. Congenital and neonatal leukemia. Semin Perinatol 1999;23(4):274-285.

Bresters D, Reus ACW, Veerman AJP, et al. Congenital leukaemia: the Dutch experience and review of the literature, Br J Haematol 2002; 117(3):513–524.

Isaacs Jr. H. Fetal and neonatal leukemia. J Pediatr Hematol Oncol 2003; 25(5):348–361.

Gruber TA, Downing JR. The biology of pediatric acute megakaryoblastic leukemia. Blood 2015; 126(8):943-949.

De Rooij JDE, Branstetter C, Ma J, et al. Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia is Characterized by Distinct Genomic Subsets with Varying Outcomes. Nat genet 2017; 49(3):451-456.

Schweitzer J, Zimmermann M, Rasche M, et al. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Ann Hematol 2015; 94:1327–1336.

Warrier RP, Emami A, Ravindranath Y et al. Perinatal Leukemia: The surface antigens, cytochemistry and cytogenetic features. Indian Pediatr 1983; 20:325-333.

Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet 2007; 143:42–50.

Lange B. The management of neoplastic disorders of haematopoiesis in children with Down’s syndrome. Br J Haematol 2000; 110:512–524.

Mathur NB, Joshi N, Singh T, Singh M. Congenital acute megakaryocytic leukemia. Indian J Med Paediatr Oncol 2011; 32(3):165-167.

Fatima Shirly AG, Darlington D. A rare case of congenital leukemia: acute myeloblastic leukemia in a neonate with Down syndrome. Int J Contemp Pediatr 2016; 3(1):288-290.

Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32:148-152

Campwell WA, Storlazzi E, Vintizileos AM. Fetal neonatal leukemia. Arch Dis Child 1962; 37:93–98.

Gamis AS, Alonzo TA, Gerbing RB, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children’s Oncology Group Study A2971. Blood 2011; 26:6752–6759.

O'Brien M, Taub J, Stine K, et al. Excessive cardiotxocity despite excellent leukemia-free survival for pediatric patients with Down syndrome and acute myeloid leukemia: results from POG (Pediatric Oncology Group) protocol 9421. Blood 2006; 108:168a-169a.

Rao A, Hills RK, Stiller C, et al. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. Br J Haematol 2006; 132:576–583.


Copyright (c) 2018 Elena Andreea Moaleș, Mirabela Smaranda Subotnicu, Denisa Boroș, Anca Ivanov, Adriana Mocanu, Magdalena Stârcea, Ingrith Miron

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975